Clinical trial Recruiting at 1 site Interventional Ages 28 Days to 17

Tracking chest and abdominal motion to detect breathing mismatch in children

Official title: Validation of a Non-Invasive Device for Thoracoabdominal Asynchrony-Based Respiratory Effort Assessment in Pediatric Patients

Run by Massachusetts General Hospital · NCT04626154 · Data updated 2026-11-12

This project will test whether small motion sensors placed on a child's chest and belly can detect mismatched breathing (thoracoabdominal asynchrony) to help guide when to start, change, or stop breathing support.

More Respiratory Insufficiency trials

Quick facts

Study typeInterventional
Ages28 Days to 17 Years
SexAll
Enrollment20 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 16, 2020
Main results expectedApril 30, 2028
Study endsJune 1, 2029
Registry record updatedJuly 13, 2026
Trial IDNCT04626154 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 28 days to 17 years who have or are at risk of respiratory distress and can safely wear sensors on their chest and abdomen are the ideal candidates.

Probably not a fit

Children with skin injury, implanted or external hardware that prevents sensor placement, or respiratory problems unrelated to thoracoabdominal asynchrony may not receive benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Investigators will use a non-invasive wearable device with motion-tracking sensors attached to the chest and abdomen to continuously record thoracoabdominal motion in children. The device will be applied to patients aged 28 days to 17 years with and without respiratory distress to compare synchrony patterns. The goal is to determine whether the device reliably detects major asynchrony events and subtler precursors that are not obvious to the naked eye. Data collection occurs at Massachusetts General Hospital and is intended to inform clinician decisions about escalating or de-escalating respiratory support.

Why it matters

Potential benefit: If successful, this device could give clinicians early, objective warnings of worsening breathing so they can adjust support sooner, potentially reducing invasive ventilation and shortening PICU stays.

How similar studies have gone: Prior research shows thoracoabdominal asynchrony is a useful marker of respiratory effort, but using simple wearable motion sensors for continuous bedside detection in pediatric patients is a relatively new approach with limited outcome data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. patients 28-days to 17-years of age
2. who have respiratory distress and those who do not have respiratory distress

Exclusion Criteria:

Hardware, clinical care, or dermal injury that would preclude the application of TAA device

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.